The Oncosearch | Oncotarget

Retraction: MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1 Retraction

Ling Xiao, Hui Zhou, Xiang-Ping Li, Juan Chen, Chao Fang, Chen-Xue Mao, Jia-Jia Cui, Wei Zhang, Hong-Hao Zhou, Ji-Ye Yin, Zhao-Qian Liu

Published Aug 23, 2024 · Vol. 15, No. 1 · pp. 590-590

Global DNA hypermethylation pattern and unique gene expression signature in liver cancer from patients with Indigenous American ancestry Research Paper

Juan Pablo Cerapio, Agnès Marchio, Luis Cano, Ignacio López, Jean-Jacques Fournié, Béatrice Régnault, Sandro Casavilca-Zambrano, Eloy Ruiz, Anne Dejean, Stéphane Bertani, Pascal Pineau

Published Feb 3, 2021 · Vol. 12, No. 5 · pp. 475-492

Keywords: hepatitis B virus, indigenous people, integrative genomics, liver cancer

Clostridium perfringens enterotoxin induces claudin-4 to activate YAP in oral squamous cell carcinomas Research Paper

Chie Nakashima, Kazuhiko Yamamoto, Shingo Kishi, Takamitsu Sasaki, Hitoshi Ohmori, Rina Fujiwara-Tani, Shiori Mori, Isao Kawahara, Yukiko Nishiguchi, Takuya Mori, Masuo Kondoh, Yi Luo, Tadaaki Kirita, Hiroki Kuniyasu

Published Jan 28, 2020 · Vol. 11, No. 4 · pp. 309-321

Keywords: clostridium perfringens enterotoxin, claudin-4, YAP, Hippo signal, oral squamous cell carcinoma, Pathology

Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation Correction

Aaditya Khatri, Jing Jin Gu, Courtney M. McKernan, Xia Xu, Ann Marie Pendergast

Published Oct 3, 2019 · Vol. 10, No. 57 · pp. 6045-6046

Correction: mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development Correction

Laura Molina, Hong Yang, Adeola O. Adebayo Michael, Michael Oertel, Aaron Bell, Sucha Singh, Xin Chen, Junyan Tao, Satdarshan P. Monga

Published Sep 20, 2019 · Vol. 10, No. 54 · pp. 5670-5670

ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation Priority Research Paper

Aaditya Khatri, Jing Jin Gu, Courtney M. McKernan, Xia Xu, Ann Marie Pendergast

Published Mar 8, 2019 · Vol. 10, No. 20 · pp. 1874-1886

mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development Research Paper

Laura Molina, Hong Yang, Adeola O. Adebayo Michael, Michael Oertel, Aaron Bell, Sucha Singh, Xin Chen, Junyan Tao, Satdarshan P.S. Monga

Published Feb 19, 2019 · Vol. 10, No. 15 · pp. 1475-1490

PKCÎ¹ and YAP1 are crucial in promoting pancreatic tumorigenesis Research Paper

Peipei Wang, Dapeng Wei, Hongmei Zhang, Jiao Chen, Dingding Zhang, Suthakar Ganapathy, Pauline Isakson, Changyan Chen, Tongbo Zhu

Published Aug 28, 2018 · Vol. 9, No. 67 · pp. 32736-32750

Loss of KIBRA function activates EGFR signaling by inducing AREG Research Paper

Ashley L. Mussell, Kayla E. Denson, He Shen, Yanmin Chen, Nuo Yang, Costa Frangou, Jianmin Zhang

Published Jul 6, 2018 · Vol. 9, No. 52 · pp. 29975-29984

Targeting loss of the Hippo signaling pathway in NF2-deficient papillary kidney cancers Research Paper

Carole Sourbier, Pei-Jyun Liao, Christopher J. Ricketts, Darmood Wei, Youfeng Yang, Sarah M. Baranes, Benjamin K. Gibbs, Lernik Ohanjanian, L.Spencer Krane, Bradley T. Scroggins, J. Keith Killian, Ming-Hui Wei, Toshiki Kijima, Paul S. Meltzer, Deborah E. Citrin, Len Neckers, Cathy D. Vocke, W. Marston Linehan

Published Jan 10, 2018 · Vol. 9, No. 12 · pp. 10723-10733

Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1 Research Paper

Andrew Fesler, Hua Liu, Jingfang Ju

Published Dec 19, 2017 · Vol. 9, No. 2 · pp. 2367-2383

PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression Research Paper

Jai-Nien Tung, Po-Lin Lin, Yao-Chen Wang, De-Wei Wu, Chi-Yi Chen, Huei Lee

Published Dec 8, 2017 · Vol. 9, No. 4 · pp. 4637-4646

YAP1 regulates prostate cancer stem cell-like characteristics to promote castration resistant growth Research Paper

Ning Jiang, Binghu Ke, Kim Hjort-Jensen, Diego Iglesias-Gato, Zhun Wang, Pengcheng Chang, Yang Zhao, Xiaodan Niu, Tao Wu, Bo Peng, Mingdong Jiang, Xiaoshi Li, Zhiqun Shang, Qiang Wang, Chawnshang Chang, Amilcar Flores-Morales, Yuanjie Niu

Published Dec 7, 2017 · Vol. 8, No. 70 · pp. 115054-115067

Clinical significance of YAP1 activation in head and neck squamous cell carcinoma Research Paper

Young-Gyu Eun, Dongjin Lee, Young Chan Lee, Bo Hwa Sohn, Eui Hyun Kim, Sun Young Yim, Kee Hwan Kwon, Ju-Seog Lee

Published Nov 27, 2017 · Vol. 8, No. 67 · pp. 111130-111143

Ascl2 activation by YAP1/KLF5 ensures the self-renewability of colon cancer progenitor cells Research Paper

Xiaolong Wei, Jun Ye, Yangyang Shang, Haoyuan Chen, Shanxi Liu, Li Liu, Rongquan Wang

Published Nov 27, 2017 · Vol. 8, No. 65 · pp. 109301-109318

Inhibition of YAP function overcomes BRAF inhibitor resistance in melanoma cancer stem cells Research Paper

Matthew L. Fisher, Daniel Grun, Gautam Adhikary, Wen Xu, Richard L. Eckert

Published Nov 22, 2017 · Vol. 8, No. 66 · pp. 110257-110272

Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer Research Paper

Sho Nambara, Takaaki Masuda, Miki Nishio, Shotaro Kuramitsu, Taro Tobo, Yushi Ogawa, Qingjiang Hu, Tomohiro Iguchi, Yousuke Kuroda, Shuhei Ito, Hidetoshi Eguchi, Keishi Sugimachi, Hiroshi Saeki, Eiji Oki, Yoshihiko Maehara, Akira Suzuki, Koshi Mimori

Published Nov 21, 2017 · Vol. 8, No. 64 · pp. 107666-107677

Small-sized colorectal cancer cells harbor metastatic tumor-initiating cells Research Paper

Lei Mu, Kaiyu Huang, Yibing Hu, Chang Yan, Xiaolan Li, Deding Tao, Jianping Gong, Jichao Qin

Published Nov 11, 2017 · Vol. 8, No. 64 · pp. 107907-107919

High frequency of radiological differential responses with poly(ADP-Ribose) polymerase (PARP) inhibitor therapy Research Paper

Raquel Perez-Lopez, Desam Roda, Begona Jimenez, Jessica Brown, Joaquin Mateo, Suzanne Carreira, Juanita Lopez, Udai Banerji, L. Rhoda Molife, Dow-Mu Koh, Stan B. Kaye, Johann S. de Bono, Nina Tunariu, Timothy A. Yap

Published Nov 6, 2017 · Vol. 8, No. 61 · pp. 104430-104443

YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways Research Paper

Daniel Andrade, Meghna Mehta, James Griffith, Janani Panneerselvam, Akhil Srivastava, Tae-Dong Kim, Ralf Janknecht, Terence Herman, Rajagopal Ramesh, Anupama Munshi

Published Oct 20, 2017 · Vol. 8, No. 58 · pp. 98495-98508

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Retraction: MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1 Retraction

Global DNA hypermethylation pattern and unique gene expression signature in liver cancer from patients with Indigenous American ancestry Research Paper

Clostridium perfringens enterotoxin induces claudin-4 to activate YAP in oral squamous cell carcinomas Research Paper

Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation Correction

Correction: mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development Correction

ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation Priority Research Paper

mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development Research Paper

PKCÎ¹ and YAP1 are crucial in promoting pancreatic tumorigenesis Research Paper

Loss of KIBRA function activates EGFR signaling by inducing AREG Research Paper

Targeting loss of the Hippo signaling pathway in NF2-deficient papillary kidney cancers Research Paper

Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1 Research Paper

PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression Research Paper

YAP1 regulates prostate cancer stem cell-like characteristics to promote castration resistant growth Research Paper

Clinical significance of YAP1 activation in head and neck squamous cell carcinoma Research Paper

Ascl2 activation by YAP1/KLF5 ensures the self-renewability of colon cancer progenitor cells Research Paper

Inhibition of YAP function overcomes BRAF inhibitor resistance in melanoma cancer stem cells Research Paper

Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer Research Paper

Small-sized colorectal cancer cells harbor metastatic tumor-initiating cells Research Paper

High frequency of radiological differential responses with poly(ADP-Ribose) polymerase (PARP) inhibitor therapy Research Paper

YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Retraction: MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1 Retraction

Global DNA hypermethylation pattern and unique gene expression signature in liver cancer from patients with Indigenous American ancestry Research Paper

Clostridium perfringens enterotoxin induces claudin-4 to activate YAP in oral squamous cell carcinomas Research Paper

Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation Correction

Correction: mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development Correction

ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation Priority Research Paper

mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development Research Paper

PKCÎ¹ and YAP1 are crucial in promoting pancreatic tumorigenesis Research Paper

Loss of KIBRA function activates EGFR signaling by inducing AREG Research Paper

Targeting loss of the Hippo signaling pathway in NF2-deficient papillary kidney cancers Research Paper

Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1 Research Paper

PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression Research Paper

YAP1 regulates prostate cancer stem cell-like characteristics to promote castration resistant growth Research Paper

Clinical significance of YAP1 activation in head and neck squamous cell carcinoma Research Paper

Ascl2 activation by YAP1/KLF5 ensures the self-renewability of colon cancer progenitor cells Research Paper

Inhibition of YAP function overcomes BRAF inhibitor resistance in melanoma cancer stem cells Research Paper

Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer Research Paper

Small-sized colorectal cancer cells harbor metastatic tumor-initiating cells Research Paper

High frequency of radiological differential responses with poly(ADP-Ribose) polymerase (PARP) inhibitor therapy Research Paper

YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways Research Paper